Dr. Byron Patrick Dubow, MD

Dr. Dubow practices at Urology Associates of the Central Coast in San Luis Obispo, California.

Dr. Dubow's NPI, 1710365671, was assigned on May 12, 2015. Dr. Dubow graduated from Vagelos College of Physicians and Surgeons in 2015. Dr. Dubow holds California license A170114.

Dr. Dubow's primary practice is Urology Associates of the Central Coast, at 225 Prado Rd, San Luis Obispo, CA 93401 in San Luis Obispo County. The practice phone is (805) 786-2500.

Dr. Dubow's primary practice is Urology Associates of the Central Coast in San Luis Obispo, California. Dr. Dubow is also affiliated with Dignity Health - French Hospital Medical Center. The medical group on file is Urology Associates of the Central Coast. Dmand AI also links Dr. Dubow to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dubow practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Dubow's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Dubow is board certified in urology by the American Board of Urology. Dmand AI has Dr. Dubow's licenses on file in 2 states: California and Oklahoma.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney disease, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Dubow treats.

CMS data shows 65,062 Medicare services from Dr. Dubow across 36 procedure codes in 2024, for 1,404 Medicare patients. Medicare paid $613,074 for them.

CMS counts 1,404 Medicare patients who saw Dr. Dubow in 2024. The largest group is 65 to 74, with 600 patients. 73% of them have high blood pressure, and 73% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dubow's median patient age at 71, with 27% women.

In 2024, Dr. Dubow wrote 5,208 Medicare Part D claims for 1,159 patients. 89% of them were for generic drugs. CMS names the drug for 5,061 of them, across 35 drugs with 11 or more claims each, at $1,980,768 in total drug cost. In 2023, CMS named 3,296 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Dubow for performance year 2024, reported as part of a group. Dr. Dubow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dubow as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Dubow, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Dubow, published from 2014 to 2017. 2014 was the busiest year, with 3. The most frequent topics are Neoplasm Grading. Dr. Dubow's most frequent co-authors are James M. McKiernan, MD, Mitchell Clark Benson, MD and Dominic Frimberger, MD.

CMS Open Payments shows 278 general payments to Dr. Dubow from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Astellas Pharma US Inc paid the most, $666.

Dr. Dubow graduated from Vagelos College of Physicians and Surgeons in 2015.

Dr. Dubow is in network with 15 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Aetna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.